SHINE's final SER for Wisconsin facility issued by NRC

March 1, 2023, 12:00PMNuclear News
SHINE’s isotope production building, called the Chrysalis, under construction in October 2022. (Photo: SHINE)

The Nuclear Regulatory Commission has issued its final safety evaluation report (SER) related to the operating license application for SHINE Technologies' large-scale medical isotope production facility, known as The Chrysalis, in Janesville, Wis. The SER documents the results of NRC staff’s technical and safety review of SHINE’s application. SHINE announced the NRC’s decision on February 27.

A record of decision concerning the proposed issuance of the operating license will be published by the NRC at a future date.

To continue reading, log in or create a free account!

Related Articles

The NRC is back to five commissioners

January 5, 2026, 10:46AMNuclear News

Douglas Weaver, nominated to the Nuclear Regulatory Commission by President Trump and confirmed by the U.S. Senate, was sworn in on December 22 as a commissioner for a term ending June 30,...